Administration of apo A-I (Milano) nanoparticles reverses pathological remodelling, cardiac dysfunction, and heart failure in a murine model of HFpEF associated with hypertension

por Mishra, Mudit, Muthuramu, Ilayaraja, Kempen, Herman, De Geest, Bart
Publicado 2020

Reconstituted HDL (Milano) Treatment Efficaciously Reverses Heart Failure with Preserved Ejection Fraction in Mice

por Mishra, Mudit, Muthuramu, Ilayaraja, Aboumsallem, Joseph Pierre, Kempen, Herman, De Geest, Bart
Publicado 2018

Effective Treatment of Diabetic Cardiomyopathy and Heart Failure with Reconstituted HDL (Milano) in Mice

por Aboumsallem, Joseph Pierre, Muthuramu, Ilayaraja, Mishra, Mudit, Kempen, Herman, De Geest, Bart
Publicado 2019

Stimulation of Hepatic Apolipoprotein A-I Production by Novel Thieno-Triazolodiazepines: Roles of the Classical Benzodiazepine Receptor, PAF Receptor, and Bromodomain Binding

por Kempen, Herman J, Bellus, Daniel, Fedorov, Oleg, Nicklisch, Silke, Filippakopoulos, Panagis, Picaud, Sarah, Knapp, Stefan
Publicado 2013

Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size

por Kempen, Herman J., Schranz, Dorota B., Asztalos, Bela F., Otvos, James, Jeyarajah, Elias, Drazul-Schrader, Denise, Collins, Heidi L., Adelman, Steven J., Wijngaard, Peter L. J.
Publicado 2014